Inventor · disambiguated record
Argaw Kidane
Also filed as: KIDANE ARGAW
26 granted patents·19 pending applications·256 citations·filing 2001–2025
96Inventor score
Top patents by PatentIndex Score
45 records- 0196US8747897B2Osmotic drug delivery systemKIDANE ARGAW·Filed 2006·Granted Jun 10, 2014·57 cites·60 claims
- 0295US8617600B2Modified release preparations containing oxcarbazepine and derivatives thereofBHATT PADMANABH P·Filed 2012·Granted Dec 31, 2013·25 cites·22 claims
- 0394US7763635B2Once daily dosage forms of trospiumSUPERMUS PHARMACEUTICALS INC·Filed 2007·Granted Jul 27, 2010·20 cites·6 claims
- 0493US7781448B2Once daily dosage forms of trospiumSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Aug 24, 2010·6 cites·44 claims
- 0593US7759359B2Method of treating bladder dysfunction with once-a-day trospium salt formulationSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Jul 20, 2010·6 cites·9 claims
- 0692US7410978B2Once daily dosage forms of trospiumSUPERNUS PHARMACEUTICALS INC·Filed 2004·Granted Aug 12, 2008·22 cites·37 claims
- 0791US7611728B2Osmotic delivery of therapeutic compounds by solubility enhancementSUPERNUS PHARMACEUTICALS INC·Filed 2003·Granted Nov 3, 2009·75 cites·17 claims
- 0890US7781449B2Trospium chloride treatment methodSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Aug 24, 2010·8 cites·26 claims
- 0988US9119792B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Sep 1, 2015·5 cites·20 claims
- 1087US7910131B2Method of treating seizures using modified release formulations of oxcarbazepineSUPERNUS PHARMACEUTICALS INC·Filed 2008·Granted Mar 22, 2011·4 cites·24 claims
- 1187US7722898B2Modified-release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted May 25, 2010·5 cites·20 claims
- 1286US2023081113A1Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1384US2023255892A1Osmotic drug delivery systemSUPERNUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1483US8017149B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·2 cites·22 claims
- 1582US10220042B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2017·Granted Mar 5, 2019·1 cites·27 claims
- 1682US9119791B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Sep 1, 2015·2 cites·24 claims
- 1780US11896599B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2019·Granted Feb 13, 2024·0 cites·20 claims
- 1880US11166960B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2021·Granted Nov 9, 2021·0 cites·6 claims
- 1979US9855278B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·1 cites·21 claims
- 2079US6656470B2Vaccine composition, method of preparing the same, and method of vaccinating vertebratesUPJOHN CO·Filed 2001·Granted Dec 2, 2003·12 cites·37 claims
- 2178US9370525B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2015·Granted Jun 21, 2016·1 cites·21 claims
- 2278US9351975B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2015·Granted May 31, 2016·1 cites·20 claims
- 2378US8821930B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2013·Granted Sep 2, 2014·1 cites·20 claims
- 2478US2023210823A1Formulations of mazindolSUPERNUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2577US2021308142A9Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2676US9393203B2Osmotic drug delivery systemSUPERNUS PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·1 cites·23 claims
- 2776US8211464B2Modified release preparations containing oxcarbazepine and derivatives thereofBHATT PADMANABH P·Filed 2011·Granted Jul 3, 2012·1 cites·26 claims
- 2872US2020261371A1Osmotic drug delivery systemSUPERNUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2971US2025161218A1Formulations of mazindolSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3070US2013089607A1Once daily trospium chloride treatment methodSUPERNUS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3168US2019336450A1Osmotic drug delivery systemSUPERNUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3265US2014303252A1Osmotic drug delivery systemSUPERNUS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3365US2010221354A1Pharmaceutical composition for once-a-day oral administration of trospium chlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3465US2010221355A1Pharmaceutical composition for once-a-day oral administration of trospium chlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3565US2010221356A1Pharmaceutical composition for once a day administration of trospium chlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3665US2010222375A1Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day AdministrationSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3762US10154965B2Osmotic drug delivery systemSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Dec 18, 2018·0 cites·17 claims
- 3862US8709476B2Compositions of quaternary ammonium compounds containing bioavailability enhancersKIDANE ARGAW·Filed 2004·Granted Apr 29, 2014·0 cites·30 claims
- 3959US7160544B2Method of vaccinating vertebratesUPJOHN CO·Filed 2003·Granted Jan 9, 2007·0 cites·65 claims
- 4059US2010221352A1Pharmaceutical composition for the once-a-day oral administration of trospium chlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4159US2010221353A1Pharmaceutical Composition For Once-A-Day Administration of Trospium ChlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4257US2006210625A1Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atomsSHIRE LAB INC·Filed 2004·Application pending·0 cites
- 4355US2013011483A1Formulations of mazindolSUPERNUS PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 4453US2016008285A1Formulations of mazindolSUPERNUS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4547US2009022789A1Enhanced formulations of lamotrigineSUPERNUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Argaw Kidane files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →